Locations:
Min Investment:
Max Investment:
Target Investment:
Bachelor's degree
2024
• Lead diligence / source new investment deals • Support portfolio companies at the board level • Manage positions in public biotech portfolio companies
2022 - 2023
2023
2023
2022
2022
2013
• Perform research in the laboratory of Dr. Christina Curtis on the genetic and epigenetic basis of drug resistance in HER2+ breast cancers via multi-omic profiling. Focus on using genome-wide sequencing assays and machine learning to understand drug response using in vitro model systems and patient data. (2015-Present) • Researcher in the laboratory of Dr. Atul Butte (now at UCSF). Worked on in silico characterization of cancer cell lines as tumor models using publicly available omics data. (2014-2015)
2023
Guest lecturer on valuation methodology - INDE 209: Analysis of Public Companies in the Life Sciences
2023 - 2024
2023 - 2024
2018 - 2021
2018 - 2021
Focused on healthcare and investment due diligence
2017 - 2018
2017 - 2018
• Equity partner and manager in small-cap biotech fund led by Stanford trainees
2017 - 2018
2017 - 2018
• Performed due diligence to identify potential new investment opportunities and develop comprehensive thesis for a particular therapeutic area • Contributed to company analysis efforts which led to investment decisions • Led key opinion leader calls, analyzed primary research literature, analyst reports to develop comprehensive commercial and scientific view of the key opportunities in the space • Synthesized and presented findings to Longitude leadership